Shares of Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $44.67.
A number of analysts recently issued reports on the stock. Northland Securities lifted their price target on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research note on Thursday, October 31st. Stifel Nicolaus upped their target price on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Evercore ISI raised Trupanion to a “strong-buy” rating in a report on Friday, August 9th. Bank of America increased their target price on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Finally, Piper Sandler upped their price target on Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a research report on Thursday, October 31st.
Get Our Latest Research Report on Trupanion
Trupanion Stock Performance
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The firm had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. During the same quarter in the prior year, the business posted ($0.10) earnings per share. Trupanion’s revenue for the quarter was up 14.6% on a year-over-year basis. On average, research analysts anticipate that Trupanion will post -0.23 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the transaction, the chief executive officer now owns 99,984 shares in the company, valued at approximately $4,647,256.32. This represents a 6.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Murray B. Low sold 2,000 shares of Trupanion stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total transaction of $105,340.00. Following the completion of the sale, the director now owns 131,513 shares in the company, valued at approximately $6,926,789.71. This represents a 1.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 10,124 shares of company stock worth $482,981 in the last three months. 5.50% of the stock is owned by insiders.
Hedge Funds Weigh In On Trupanion
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Quest Partners LLC acquired a new position in Trupanion during the 3rd quarter worth $37,000. GAMMA Investing LLC lifted its holdings in Trupanion by 70.4% in the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after purchasing an additional 596 shares during the period. Entropy Technologies LP bought a new position in Trupanion in the 3rd quarter valued at about $202,000. Mutual of America Capital Management LLC acquired a new position in Trupanion during the 3rd quarter valued at about $210,000. Finally, Headlands Technologies LLC bought a new stake in shares of Trupanion during the 2nd quarter worth about $162,000.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- Do ETFs Pay Dividends? What You Need to Know
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- How to Start Investing in Real Estate
- Applied Materials Market Capitulates: Now is the Time to Buy
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.